Biomedica Italia renews its partnership with the company RTI Surgical.

13/09/2023 News

RTI Surgical is a leading global medical device company, headquartered in the United States.
Through the 2008 merger with the company Tutogen Medical GmbH, RTI inherited decades of experience in the sterilization and preservation of tissue processed by the Tutoplast® Tissue Sterilization Process.
RTI is committed to advancing science, safety and innovation for tissue-based implants used in general surgery, reconstructive plastic surgery, spinal surgery, orthopedics, and traumatology.

Globally, more than 11 million tissue-based implants sterilized through RTI’s proprietary validated sterilization processes have been distributed with zero confirmed incidence of implant-associated infection.

The renewal of this partnership, which has lasted for many years, demonstrates the reliability and professionalism of Biomedica Italia as a partner in the healthcare sector.